Piper Serica runs 30% pharma bet on CDMOs and innovation, shuns commodity generics

Fund manager Abhay Agarwal is heavily overweight India pharma but targets innovative formulations and contract manufacturing over traditional volume-driven generics, citing global outsourcing tailwinds.

bt-corporate · 7/13/2026, 2:03:33 PM · Ask about this →